Mylan Institutional LLC et al v. Aurobindo Pharma Ltd et al
2:16-cv-00491 | Texas Eastern District Court
Interested in this case?
Request a Demo Track this case, and find millions of cases like it, let us show you how.Filing Date | # | Docket Text |
---|---|---|
8/2/2017 | 186 | Notice of Filing of Patent/Trademark Form (AO 120) at termination of case. AO 120 mailed to the Director of the U.S. Patent and Trademark Office. (slo, ) (Entered: 08/02/2017) |
8/1/2017 | 185 | ORDER GRANTING JOINT MOTION TO DISMISS AND STIPULATION. All claims, defenses, and counterclaims between Plaintiffs and Defendants are dismissed WITH prejudice. Signed by Magistrate Judge Roy S. Payne on 8/1/2017. (slo, ) (Entered: 08/02/2017) |
7/31/2017 | 184 | Joint SEALED MOTION TO DISMISS AND STIPULATION by Mylan Institutional LLC. (Attachments: # 1 Text of Proposed Order)(Smith, Melissa) (Entered: 07/31/2017) |
7/27/2017 | 183 | MANDATE of USCA-FEDERAL CIRCUIT in accordance with the judgment entered May 19, 2017, as to 126 Notice of Appeal - FEDERAL CIRCUIT filed by Aurobindo Pharma Ltd, AuroMedics Pharma LLC, Aurobindo Pharma USA Inc. (dlc, ) (Entered: 07/27/2017) |
7/21/2017 | 182 | ORDER granting 181 Sealed Patent Motion to Stay All Deadlines. (All deadlines in the Docket Control Order, all discovery and briefing, or otherwise, is stayed ten (10) calendar days from issuance of this Order.) Signed by Magistrate Judge Roy S. Payne on 7/21/2017. (slo, ) (Entered: 07/21/2017) |
7/19/2017 | 181 | Joint SEALED PATENT MOTION to Stay and Notice of Settlement by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Attachments: # 1 Email, # 2 Text of Proposed Order)(Jones, Michael) (Entered: 07/19/2017) |
7/19/2017 | ***FILED IN ERROR, PER ATTORNEY. Document # 179,. PLEASE IGNORE. Attorney has refiled. See Document 180 *** (slo, ) (Entered: 07/19/2017) | |
7/18/2017 | 180 | SEALED PATENT DOCUMENT, Corrected CounterclaimDefendants' Answer to Counterclaim-Plaintiffs' Counterclaims. (Allen, Aden) (Entered: 07/18/2017) |
7/18/2017 | 179 | ** FILED IN ERROR, PER ATTORNEY. PLEASE IGNORE. **SEALED PATENT DOCUMENT - CounterclaimDefendants' Answer to Counterclaim-Plaintiffs' Counterclaims. (Allen, Aden) Modified on 7/19/2017 (slo, ). (Entered: 07/18/2017) |
7/14/2017 | 178 | REPLY to Response to Motion re 165 MOTION to Dismiss for Improper Venue or to Transfer filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Jones, Michael) (Entered: 07/14/2017) |
7/13/2017 | 177 | ORDER appointing technical advisor. (Dr. Brent Bellows appointed as technical advisor in this case. ) Signed by Magistrate Judge Roy S. Payne on 7/13/2017. (slo, ) (Entered: 07/14/2017) |
7/6/2017 | 176 | SEALED RESPONSE to Motion re 165 MOTION to Dismiss for Improper Venue or to Transfer filed by Apicore US LLC, Mylan Institutional LLC. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Text of Proposed Order)(Smith, Melissa) (Entered: 07/06/2017) |
7/6/2017 | 175 | AMENDED AGREED DOCKET CONTROL ORDER re 173 Joint MOTION to Amend/Correct 118 Order, Terminate Motions, Scheduling Order. (Pretrial Conference set for 3/20/2018 09:00 AM in Mag Ctrm (Marshall) before Magistrate Judge Roy S. Payne, Amended Pleadings due by 8/30/2017, Jury Selection set for 4/16/2018 09:00 AM in Marshall Courthouse before Judge Robert W. Schroeder III, Markman Hearing set for 9/19/2017 09:00 AM in Mag Ctrm (Marshall) before Magistrate Judge Roy S. Payne, Motions due by 3/5/2018, Proposed Pretrial Order due by 3/12/2018.) Signed by Magistrate Judge Roy S. Payne on 7/6/2017. (slo, ) (Entered: 07/06/2017) |
7/5/2017 | 174 | SEALED PATENT DOCUMENT - Defendants' Second Amended Answer and Counterclaims to the First Amended Complaint for Patent Infringement. (Attachments: # 1 Ex. A - '992 patent, # 2 Ex. B - '616 patent, # 3 Ex. C - '050 patent, # 4 Ex. D - Tharial Depo Trans, # 5 Ex. E - ILA - ISB notes, # 6 Ex. F - API-AUR 05100, # 7 Ex. G - API-AUR 07879, # 8 Ex. H - Gibson-ISB 0290, # 9 Ex. I - Gibson Depo Trans, # 10 Ex. J - '992 File Wrapper and Contents, # 11 Ex. K - Electronic Patent App Fee Transmittal, # 12 Ex. L - '616 File Wrapper and Contents)(Jones, Michael) (Entered: 07/05/2017) |
7/5/2017 | 173 | Joint MOTION to Amend/Correct 118 Order, Terminate Motions, Scheduling Order,,, by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Attachments: # 1 Amended Agreed Docket Control Order)(Jones, Michael) (Entered: 07/05/2017) |
6/30/2017 | 172 | SEALED PATENT SUR-REPLY to Reply to Response to PATENT Motion re 162 SEALED PATENT MOTION for Leave to Serve Amended Invalidity Contentions filed by Apicore US LLC, Mylan Institutional LLC. (Smith, Melissa) (Entered: 06/30/2017) |
6/27/2017 | 171 | SEALED Joint Patent Rule 4-3, Claim Construction and Prehearing Statement. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Smith, Melissa) (Entered: 06/27/2017) |
6/27/2017 | 170 | ORDER granting 169 Motion for Extension of Time to File Response/Reply. (Plaintiffs deadline to respond to Defendants Motion to Dismiss for Improper Venue or to Transfer is extended up to and including July 6, 2017.) Signed by Magistrate Judge Roy S. Payne on 6/27/2017. (slo, ) (Entered: 06/27/2017) |
6/26/2017 | 169 | Unopposed MOTION for Extension of Time to File Response/Reply as to 165 MOTION to Dismiss for Improper Venue or to Transfer by Apicore US LLC, Mylan Institutional LLC. (Attachments: # 1 Text of Proposed Order)(Phillips, Anna) (Entered: 06/26/2017) |
6/23/2017 | 168 | SEALED PATENT REPLY to Response to PATENT Motion re 162 SEALED PATENT MOTION for Leave to Serve Amended Invalidity Contentions filed by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Attachments: # 1 Ahn Declaration, # 2 Exhibit A - Subpoena to Metro Legal)(Jones, Michael) (Entered: 06/23/2017) |
6/15/2017 | 167 | SEALED RESPONSE to Motion re 162 SEALED PATENT MOTION for Leave to Serve Amended Invalidity Contentions filed by Apicore US LLC, Mylan Institutional LLC. (Attachments: # 1 Affidavit S. Sedghani, # 2 Exhibit Ex. 01, # 3 Ex. 02, # 4 Ex. 03-1, # 5 Ex. 03-2, # 6 Ex. 04, # 7 Ex. 05, # 8 Ex. 06, # 9 Ex. 07, # 10 Ex. 08, # 11 Ex. 09, # 12 Ex. 10, # 13 Ex. 11, # 14 Ex. 12, # 15 Text of Proposed Order)(Smith, Melissa) (Entered: 06/15/2017) |
6/14/2017 | 166 | NOTICE by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc. re 165 MOTION to Dismiss for Improper Venue or to Transfer of Supplemental Authority (Attachments: # 1 Ex. A - Stuebing v. Gavronsky)(Jones, Michael) (Entered: 06/14/2017) |
6/12/2017 | 165 | MOTION to Dismiss for Improper Venue or to Transfer by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Attachments: # 1 Ex. A - Cobalt Boats Opinion, # 2 Order granting Motion to Dismiss, # 3 Order granting Motion to Transfer)(Jones, Michael) (Entered: 06/12/2017) |
6/2/2017 | 164 | ORDER granting 163 Unopposed MOTION for Leave to File the Declarations of John Doe and Dr. James Roe for In Camera Inspection Only filed by Aurobindo Pharma Ltd, AuroMedics Pharma LLC, Aurobindo Pharma USA Inc. Signed by Magistrate Judge Roy S. Payne on 6/2/2017. (slo, ) (Entered: 06/02/2017) |
6/1/2017 | 163 | Unopposed MOTION for Leave to File the Declarations of John Doe and Dr. James Roe for In Camera Inspection Only by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Attachments: # 1 John Doe - submitted for In Camera, # 2 Dr. James Roe - submitted for In Camera, # 3 Text of Proposed Order)(Jones, Michael) (Entered: 06/01/2017) |
6/1/2017 | 162 | SEALED PATENT MOTION for Leave to Serve Amended Invalidity Contentions by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Attachments: # 1 Declaration of G. Yu, # 2 Ex. A - Defendants' Amended Invalidity Contentions, # 3 Ex. B - Defendants' Initial Invalidity Contentions, # 4 Ex. C - Feb. 23, 1979 Sigma to FDA letter, # 5 Ex. D - March 5, 1979 Sigma to Hirsch letter, # 6 Ex. E - Alexsam v. Evolution, # 7 Text of Proposed Order)(Jones, Michael) (Entered: 06/01/2017) |
5/26/2017 | 161 | AMENDED ANSWER to 12 Amended Complaint, by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc.. (Jones, Michael) (Entered: 05/26/2017) |
5/19/2017 | 160 | NOTICE OF ENTRY OF USCA-FEDERAL CIRCUIT JUDGMENT ACCOMPANIED BY OPINION affirming the District Court as to 126 Notice of Appeal - FEDERAL CIRCUIT filed by Aurobindo Pharma Ltd, AuroMedics Pharma LLC, Aurobindo Pharma USA Inc. The mandate will be issued in due course. Decided: May 19, 2017. Circuit Judges: Lourie, Moore, and Reyna. (Attachments: # 1 USCA-Federal Circuit Opinion, # 2 Rehearing Info Sheet, # 3 Supreme Court Info Sheet)(dlc, ) (Entered: 05/19/2017) |
5/15/2017 | 159 | NOTICE of Attorney Appearance - Pro Hac Vice by Stuart A Williams on behalf of Mylan Institutional LLC. Filing fee $ 100, receipt number 0540-6293650. (Williams, Stuart) (Entered: 05/15/2017) |
4/20/2017 | 158 | ORDER of USCA-FEDERAL CIRCUIT denying petition for writ of mandamus. (dlc, ) (Entered: 04/20/2017) |
4/20/2017 | 157 | ORDER of USCA-FEDERAL CIRCUIT denying the motion to file petition for writ of mandamus under seal. Petitioners are directed to file corrected confidential and nonconfidential versions of their petition within 7 days. Issued: April 20, 2017. (dlc, ) (Entered: 04/20/2017) |
4/6/2017 | 156 | ACKNOWLEDGMENT OF RECEIPT on 4/6/17 by USCA-Federal Circuit as to 101 Report and Recommendations, 155 Amended Notice of Appeal - PATENT CASE, 139 Order, 154 Order, 122 Order Adopting Report and Recommendations, and certified copy of Docket Sheet. (dlc, ) (Entered: 04/10/2017) |
4/6/2017 | Transmission of Amended Notice of Appeal, 154 Order, 139 Order, 122 Order, 101 Report & Recommendation, and certified copy of Docket Sheet to US Court of Appeals, Federal Circuit by separate email. re 155 Amended Notice of Appeal - FEDERAL CIRCUIT (dlc, ) (Entered: 04/06/2017) | |
4/5/2017 | 155 | AMENDED NOTICE OF APPEAL - PATENT CASE as to 126 Notice of Appeal - FEDERAL CIRCUIT by AuroMedics Pharma LLC, Aurobindo Pharma Ltd, Aurobindo Pharma USA Inc. (Clutter, Patrick) (Entered: 04/05/2017) |
3/24/2017 | 154 | ORDER RE 138 Emergency SEALED PATENT MOTION to Expedite Entry of a Preliminary Injunction. Order is effective immediately and shall remain in effect until further order of this Court dissolving the Preliminary Injunction. Signed by Judge Robert W. Schroeder, III on 3/24/2017. (slo, ) (Entered: 03/24/2017) |
3/10/2017 | 153 | ORDER of USCA-FEDERAL CIRCUIT denying motion for emergency stay. The appellees are directed to file paper versions of brief contemporaneously with their filing of the electronic version of the brief. The appellants are directed to file paper versions of the reply brief and joint appendix contemporaneously with the electronic filing of those documents. Oral argument on the merits will be held on April 10, 2017 at 10am. Issued: March 10, 2017. (dlc, ) (Entered: 03/10/2017) |
3/10/2017 | 152 | SEALED PATENT DOCUMENT. REPLY IN SUPPORT OF 145 NOTICE OF SUPPLEMENT TO EMERGENCY MOTION TO EXPEDITE ENTRY OF A PRELIMINARY INJUNCTION AND JOINT SUBMISSION REGARDING PRELIMINARY INJUNCTION ORDER (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit Supplemental Declaration of Heather Paton, # 5 Exhibit Paton Decl. Ex. A, # 6 Exhibit Supplemental Declaration of Ravishanker Kovi,)(Smith, Melissa) (Entered: 03/10/2017) |
3/8/2017 | 151 | ORDER of USCA-FEDERAL CIRCUIT denying motion to file under seal. The documents previously offered under seal will remain confidential and thus not viewable by the public. Within 7 days of the date of this order, the appellants are directed to file corrected confidential and nonconfidential versions of their response to the motion to stay and their response to the motion to expedite as to 126 Notice of Appeal - FEDERAL CIRCUIT filed by Aurobindo Pharma Ltd, AuroMedics Pharma LLC, Aurobindo Pharma USA Inc. Issued: March 8, 2017. (dlc, ) (Entered: 03/08/2017) |
3/7/2017 | 150 | SEALED PATENT RESPONSE by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd, AuroMedics Pharma LLC to 145 Sealed Document - Response to Plaintiffs' Notice of Supplement to Plaintiffs' Emergency Motion to Expedite Entry of a Preliminary Injunction and Joint Submission regarding Preliminary Injunction Order, filed by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd, AuroMedics Pharma LLC. (Attachments: # 1 Exhibit A - Email from Michael Kopp, # 2 Fedele Declaration, # 3 Exhibit 1 - March-Dec 2016 Net Sales, # 4 Exhibit 2 - Bloomberg news article, # 5 Exhibit 3 - Email from Mark Fedele, # 6 Exhibit 4 - Letter to Cardinal)(Jones, Michael) (Entered: 03/07/2017) |
3/7/2017 | 149 | ORDER of USCA-FEDERAL CIRCUIT ordering Mylan Institutional LLC and Apicore US LLC to respond to the petition for a writ of mandamus within 10 days from the date of filing of this order. Any reply must be received within five days from the date of filing of the response. Issued: March 7, 2017. (dlc, ) (Entered: 03/07/2017) |